Journal of Clinical Endocrinology & Metabolism, Vol 76, 736-741, Copyright © 1993 by Endocrine Society

ARTICLES

The identification of a human myometrial corticotropin-releasing hormone receptor that increases in affinity during pregnancy

EW Hillhouse, D Grammatopoulos, NG Milton and HW Quartero
Department of Clinical Biochemistry and Metabolic Medicine, University of Newcastle, United Kingdom.

The concentration of immunoreactive, placentally derived CRH is increased in the peripheral circulation during the third trimester of human pregnancy. However, the function of this placental CRH is entirely unknown. A number of observations have led us to believe that CRH might influence myometrial contractility and, hence, parturition via specific receptor mechanisms. 1) In idiopathic preterm labor, plasma immunoreactive-CRH concentrations are significantly elevated compared to control values. 2) CRH and oxytocin exhibit a marked synergistic effect on myometrial contractility which is prostaglandin dependent and can be inhibited by the CRH receptor antagonist [alpha- helical CRF-(9-41)]. In view of this, we searched for specific CRH- binding sites in myometrial tissue obtained at biopsy from pregnant (cesarian section) and nonpregnant (hysterectomy) patients. To test for the presence of CRH receptors, we prepared myometrial membranes and performed binding studies using [125I]tyr-o-CRH as a ligand. The binding was found to be pH, time, temperature, and divalent cation concentration dependent and was fully reversible on addition of 1 microM unlabeled ovine CRH. In both tissues, there was a single, specific, homogenous, high affinity population of CRH receptors. Scatchard analysis of the specific binding sites revealed dissociation constants of 250-300 and 30-60 pM for the nonpregnant and pregnant myometrium, respectively. This compares with dissociation constants of 130 pM (rat anterior pituitary receptor) and 100 pM (human CRH-binding protein). This would mean that in the nonpregnant state, the equilibrium for binding is in favor of the binding protein, but during the later stages of pregnancy, the change in affinity of the receptor alters the binding in favor of the myometrial receptor.

This article has been cited by other articles:

				D. Markovic, M. Vatish, M. Gu, D. Slater, R. Newton, H. Lehnert, and D. K. Grammatopoulos The Onset of Labor Alters Corticotropin-Releasing Hormone Type 1 Receptor Variant Expression in Human Myometrium: Putative Role of Interleukin-1{beta} Endocrinology, July 1, 2007; 148(7): 3205 - 3213. [Abstract] [Full Text] [PDF]

				A.-M. Bamberger, V. Minas, S. N. Kalantaridou, J. Radde, H. Sadeghian, T. Loning, I. Charalampopoulos, J. Brummer, C. Wagener, C. M. Bamberger, et al. Corticotropin-Releasing Hormone Modulates Human Trophoblast Invasion through Carcinoembryonic Antigen-Related Cell Adhesion Molecule-1 Regulation Am. J. Pathol., January 1, 2006; 168(1): 141 - 150. [Abstract] [Full Text] [PDF]

				T.-M. Mignot, B. Paris, B. Carbonne, C. Vauge, F. Ferre, and D. Vaiman Corticotropin-releasing hormone effects on human pregnant vs. nonpregnant myometrium explants estimated from a mathematical model of uterine contraction J Appl Physiol, September 1, 2005; 99(3): 1157 - 1163. [Abstract] [Full Text] [PDF]

				R. A. Mancuso, C. D. Schetter, C. M. Rini, S. C. Roesch, and C. J. Hobel Maternal Prenatal Anxiety and Corticotropin-Releasing Hormone Associated With Timing of Delivery Psychosom Med, September 1, 2004; 66(5): 762 - 769. [Abstract] [Full Text] [PDF]

				E. Aggelidou, E. W. Hillhouse, and D. K. Grammatopoulos Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells PNAS, February 14, 2002; (2002) 52296399. [Abstract] [Full Text] [PDF]

				E. Karteris, H. S. Randeva, D. K. Grammatopoulos, R. B. Jaffe, and E. W. Hillhouse Expression and Coupling Characteristics of the CRH and Orexin Type 2 Receptors in Human Fetal Adrenals J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4512 - 4519. [Abstract] [Full Text] [PDF]

				C. HOLZMAN, J. JETTON, T. SILER-KHODR, R. FISHER, and T. RIP Second Trimester Corticotropin-Releasing Hormone Levels in Relation to Preterm Delivery and Ethnicity Obstet. Gynecol., May 1, 2001; 97(5): 657 - 663. [Abstract] [Full Text] [PDF]

				D. K. Grammatopoulos, Y. Dai, H. S. Randeva, M. A. Levine, E. Karteris, A. J. Easton, and E. W. Hillhouse A Novel Spliced Variant of the Type 1 Corticotropin-Releasing Hormone Receptor with a Deletion in the Seventh Transmembrane Domain Present in the Human Pregnant Term Myometrium and Fetal Membranes Mol. Endocrinol., December 1, 1999; 13(12): 2189 - 2202. [Abstract] [Full Text]

				R. Smith, E. J. Wickings, M. E. Bowman, A. Belleoud, G. Dubreuil, J. J. Davies, and G. Madsen Corticotropin-Releasing Hormone in Chimpanzee and Gorilla Pregnancies J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2820 - 2825. [Abstract] [Full Text]

				H. Kobayashi, G. W. Sun, and T. Terao Urinary trypsin inhibitor down-regulates hyaluronic acid fragment-induced prostanoid release in cultured human amnion cells by inhibiting cyclo-oxygenase-2 expression Mol. Hum. Reprod., July 1, 1999; 5(7): 662 - 667. [Abstract] [Full Text] [PDF]

				D. K. Grammatopoulos and E. W. Hillhouse Basal and Interleukin-1{beta}-Stimulated Prostaglandin Production from Cultured Human Myometrial Cells: Differential Regulation by Corticotropin- Releasing Hormone J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2204 - 2211. [Abstract] [Full Text]

				F. M. Reis, M. Fadalti, P. Florio, and F. Petraglia Putative Role of Placental Corticotropin-Releasing Factor in the Mechanisms of Human Parturition Reproductive Sciences, May 1, 1999; 6(3): 109 - 119. [Abstract] [PDF]

				S.A. Alvi, N.L. Brown, P.R. Bennett, M.G. Elder, and M.H.F. Sullivan Corticotrophin-releasing hormone and platelet-activating factor induce transcription of the type-2 cyclo-oxygenase gene in human fetal membranes Mol. Hum. Reprod., May 1, 1999; 5(5): 476 - 480. [Abstract] [Full Text] [PDF]

				M. Y. Stevens, J. R. G. Challis, and S. J. Lye Corticotropin-Releasing Hormone Receptor Subtype 1 Is Significantly Up-Regulated at the Time of Labor in the Human Myometrium J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4107 - 4115. [Abstract] [Full Text]

				V. L. Clifton, J. F. Telfer, A. J. Thompson, I. T. Cameron, T. G. Teoh, S. J. Lye, and J. R. G. Challis Corticotropin-Releasing Hormone and Proopiomelanocortin-Derived Peptides Are Present in Human Myometrium J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3716 - 3721. [Abstract] [Full Text]

				D. Grammatopoulos, Y. Dai, J. Chen, E. Karteris, N. Papadopoulou, A. J. Easton, and E. W. Hillhouse Human Corticotropin-Releasing Hormone Receptor: Differences in Subtype Expression between Pregnant and Nonpregnant Myometria J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2539 - 2544. [Abstract] [Full Text]

				M. L. Casey, J. Smith, G. Alsabrook, and P. C. MacDonald Activation of Adenylyl Cyclase in Human Myometrial Smooth Muscle Cells by Neuropeptides J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3087 - 3092. [Abstract] [Full Text] [PDF]

				S. Mesiano and R. B. Jaffe Developmental and Functional Biology of the Primate Fetal Adrenal Cortex Endocr. Rev., June 1, 1997; 18(3): 378 - 403. [Abstract] [Full Text]

				E. Aggelidou, E. W. Hillhouse, and D. K. Grammatopoulos Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells PNAS, March 5, 2002; 99(5): 3300 - 3305. [Abstract] [Full Text] [PDF]